📖

CRISPRi Epigenetic Silencing of SNCA for Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-ideas-payload-crispri-snca-silencin

Related Entities

ideas-payload-crispri-snca-silencing

Metadata

slug	ideas-payload-crispri-snca-silencing
entity_type	idea
kg_node_id	None

Linked Artifacts (344)

mentions🧪Smartphone-Detected Motor Variability Correction70%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade70%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation70%

related🧫CRISPR Gene Correction Approaches for CBS/PSP70%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%

related🧫CRISPR Gene Correction Approaches for CBS/PSP70%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%

related🧪Smartphone-Detected Motor Variability Correction63%

related🧪Enteric Nervous System Prion-Like Propagation Blockade63%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation63%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%

related🧫AAV-LRRK2 IND-Enabling Study Design60%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%

related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%

related🧫Alpha-Synuclein Seed Amplification Assay Validation60%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%

related🧫Antiviral Therapy Trial for Parkinson's Disease60%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%

related🧫Combination Therapy Sequencing in Parkinson's Disease60%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%

related🧫Ferroptosis Validation in Parkinson's Disease60%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%

related🧫Cytochrome Therapeutics60%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%

related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%

related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%

related🧫Macroautophagy Dysfunction in PD - Experiment Design60%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%

related🧫Validation: Membrane-Nucleation in iPSC Neurons60%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%

related🧫MLCS Quantification in Parkinson's Disease60%

related🧫Experiment: Multi-Ethnic PD GWAS60%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%

related🧫Parkinson's Disease Subtype Classification — Precision 60%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%

related🧫Prodromal Parkinson's Disease Biomarker Development — E60%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%

related🧫AAV-LRRK2 IND-Enabling Study Design54%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%

related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%

related🧫Alpha-Synuclein Seed Amplification Assay Validation54%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%

related🧫Antiviral Therapy Trial for Parkinson's Disease54%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%

related🧫Combination Therapy Sequencing in Parkinson's Disease54%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%

related🧫Ferroptosis Validation in Parkinson's Disease54%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%

related🧫Cytochrome Therapeutics54%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%

related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%

related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%

related🧫Macroautophagy Dysfunction in PD - Experiment Design54%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%

related🧫Validation: Membrane-Nucleation in iPSC Neurons54%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%

related🧫MLCS Quantification in Parkinson's Disease54%

related🧫Experiment: Multi-Ethnic PD GWAS54%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%

related🧫Parkinson's Disease Subtype Classification — Precision 54%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%

related🧫Prodromal Parkinson's Disease Biomarker Development — E54%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP50%

mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice50%

mentions🧫TLR expression in α-synuclein overexpressing mice50%

mentions🧫Dexamethasone treatment study in α-synuclein mice50%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%

mentions🧪APOE-Dependent Autophagy Restoration50%

mentions🧪Epigenetic Memory Erasure via TET2 Activation50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

mentions🧪Cryptic Exon Silencing Restoration50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%

related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

related🔬What are the most promising therapeutic strategies for targe50%

related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%

related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%

related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%

related🔬Epigenetic clocks and biological aging in neurodegeneration50%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%

see_also📖Exosomal Biomarkers in Neurodegeneration45%

see_also📖Exosomal miR-155 in Neurodegeneration45%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%

see_also📖Liquid Biopsy in Neurodegeneration45%

see_also📖Metabolomic Biomarkers in Neurodegeneration45%

see_also📖Neuroimaging Biomarkers for Neurodegeneration45%

see_also📖Synaptic Biomarkers in Neurodegeneration45%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and45%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%

see_also📖China Neurodegeneration Epidemiology45%

see_also📖DALY Methodology — Neurodegeneration45%

see_also📖Disease Progression & Staging in Neurodegeneration45%

see_also📖Economic Burden — Neurodegeneration45%

see_also📖European Neurodegeneration Epidemiology45%

see_also📖Familial vs Sporadic Neurodegeneration Comparison45%

see_also📖Global Neurodegeneration Epidemiology45%

see_also📖India Neurodegeneration Epidemiology45%

see_also📖Japan Neurodegeneration Epidemiology45%

see_also📖Manganese-Related Neurodegeneration (Manganism)45%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%

see_also📖Potential Impact Measures — Neurodegeneration45%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%

see_also📖Sleep Disorders in Neurodegeneration45%

see_also📖SNCA A53T45%

see_also📖SNCA Gene Variants and Mutations45%

see_also📖US Neurodegeneration Epidemiology45%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page45%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread45%

see_also📖acetylcholine-signaling-neurodegeneration45%

see_also📖Advanced Glycation End Products in Neurodegeneration45%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%

see_also📖Amylin Signaling in Neurodegeneration45%

see_also📖Antibody Therapy in Neurodegeneration45%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%

see_also📖Autosis Pathway in Neurodegeneration45%

see_also📖Axon Guidance Pathways in Neurodegeneration45%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%

see_also📖CaMKII Signaling Pathway in Neurodegeneration45%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration45%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration45%

see_also📖Cholinergic System Dysfunction in Neurodegeneration45%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%

see_also📖Neural Circuits in Neurodegeneration45%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%

see_also📖Computational Disease Models for Neurodegeneration45%

see_also📖Convergent Pathways in Neurodegeneration45%

see_also📖Copper Homeostasis in Neurodegeneration45%

see_also📖COVID-19 Neurodegeneration Mechanism45%

see_also📖Diffusion MRI (DTI) in Neurodegeneration45%

see_also📖Digital Phenotyping in Neurodegeneration45%

see_also📖Down Syndrome Neurodegeneration Pathway45%

see_also📖Dystrophic Neurites in Neurodegeneration45%

see_also📖Endocannabinoid System in Neurodegeneration45%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%

see_also📖Endosomal Sorting Defects in Neurodegeneration45%

see_also📖Endothelin Signaling Pathway in Neurodegeneration45%

see_also📖epigenetics-neurodegeneration45%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%

see_also📖FA2H-Associated Neurodegeneration Pathway45%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%

see_also📖Galectin-3 Mechanism in Neurodegeneration45%

see_also📖Gangliosides in Neurodegeneration45%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%

see_also📖GDNF Signaling Pathway in Neurodegeneration45%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%

see_also📖Glycosylation in Neurodegeneration45%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%

see_also📖Hippocampal Neurogenesis in Neurodegeneration45%

see_also📖Histone Modification Pathways in Neurodegeneration45%

see_also📖HMGB1 Signaling in Neurodegeneration45%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%

see_also📖IL-1 Signaling Pathway in Neurodegeneration45%

see_also📖Integrated Stress Response in Neurodegeneration45%

see_also📖interleukin-6-signaling-neurodegeneration45%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%

see_also📖Kidney-Brain Neurodegeneration Axis45%

see_also📖Lipid Dysregulation in Neurodegeneration45%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%

see_also📖Metal Homeostasis in Neurodegeneration45%

see_also📖Microglial Priming Pathway in Neurodegeneration45%

see_also📖MicroRNA Dysfunction in Neurodegeneration45%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%

see_also📖Mitochondrial Fusion in Neurodegeneration45%

see_also📖Molecular Chaperones in Neurodegeneration45%

see_also📖mTOR Signaling in Neurodegeneration45%

see_also📖mTOR Signaling Pathway in Neurodegeneration45%

see_also📖Neural Circuit Disruption in Neurodegeneration45%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%

see_also📖Neuronal Hyperexcitability in Neurodegeneration45%

see_also📖Neuropil Threads in Neurodegeneration45%

see_also📖Neurotensin Signaling in Neurodegeneration45%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration45%

see_also📖NF-kB Signaling Pathway in Neurodegeneration45%

see_also📖Nitric Oxide Signaling in Neurodegeneration45%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%

see_also📖Neuropeptide Y Signaling in Neurodegeneration45%

see_also📖NRF2 Signaling Pathway in Neurodegeneration45%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%

see_also📖Orexin Signaling in Neurodegeneration45%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%

see_also📖Paranodal Dysfunction in Neurodegeneration45%

see_also📖Paraptosis in Neurodegeneration45%

see_also📖Parthanatos in Neurodegeneration45%

see_also📖Pericyte Loss in Neurodegeneration45%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration45%

see_also📖PKR Pathway in Neurodegeneration45%

see_also📖PPAR Signaling Pathway in Neurodegeneration45%

see_also📖Prion Diseases in Neurodegeneration45%

see_also📖Prion-Like Spread in Neurodegeneration45%

see_also📖Prion Protein Metabolism in Neurodegeneration45%

see_also📖Progesterone Signaling Pathway in Neurodegeneration45%

see_also📖Prognostic Biomarkers in Neurodegeneration45%

see_also📖Protein Aggregation Comparison in Neurodegeneration45%

see_also📖Protein Aggregation Seeds in Neurodegeneration45%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%

see_also📖Purinergic Signaling in Neurodegeneration45%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%

see_also📖R-Loop Stress in Neurodegeneration45%

see_also📖RAN Translation in Neurodegeneration45%

see_also📖Retinal Degeneration Pathway in Neurodegeneration45%

see_also📖Ribosome Dysfunction in Neurodegeneration45%

see_also📖RNA Splicing in Neurodegeneration45%

see_also📖RNA-Targeted Therapies in Neurodegeneration45%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%

see_also📖Senescent Cell Clearance in Neurodegeneration45%

see_also📖Serotonergic Dysfunction in Neurodegeneration45%

see_also📖Sex Differences in Neurodegeneration45%

see_also📖Short Chain Fatty Acids in Neurodegeneration45%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%

see_also📖Sleep Dysfunction in Neurodegeneration45%

see_also📖SUMOylation in Neurodegeneration45%

see_also📖synaptic-vesicle-cycling-neurodegeneration45%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%

see_also📖T-Cell Dysfunction in Neurodegeneration45%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%

see_also📖Therapeutic Targets in Neurodegeneration45%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%

see_also📖Vagus Nerve Pathway in Neurodegeneration45%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%

mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model44%

mentions🧫iPSC-NPC transplantation in ICH animal model44%

mentions🧫AMPK knockdown validation experiment44%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

mentions🔬Epigenetic clocks and biological aging in neurodegeneration40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%

mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%

mentions🔬What are the mechanisms underlying what are the mechanisms b40%

related🧪Cryptic Exon Silencing Restoration40%

related🧪Epigenetic Memory Erasure via TET2 Activation40%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%